Speakers

Joshua Salsi is the Head of North America at Biocon Biologics. As a healthcare leader, Josh has spent his 20+ year career building and leading teams focused on improving access, affordability and overall patient utility of pharmaceuticals.

Prior to joining Biocon Biologics, Josh was Vice President, Head of Oncology and Biosimilars at Viatris (formerly Mylan). From 2002 to 2015, Josh held various commercial positions at Pfizer, predominantly in their Specialty and Oncology businesses.

Josh received a BS in Microbiology from Duquesne University and an MBA also from Duquesne. He resides outside of Pittsburgh, Pennsylvania with his family.